Hideki Shimodaira

Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui et al. · Journal of Clinical Oncology · 2013 · 559 citations

Medicine, Oncology, Pharmacology +10

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 219 citations

Medicine, Oncology, Pharmacology +7

Screening thep53 status of human cell lines using a yeast functional assay

Liqun Jia, Motonobu Osada, Chikashi Ishioka et al. · Molecular Carcinogenesis · 1997 · 178 citations

Life Sciences, Molecular Biology, Molecular Genetics +14

Interaction of mismatch repair protein PMS2 and the p53-related transcription factor p73 in apoptosis response to cisplatin

Hideki Shimodaira, Atsuko Yoshioka-Yamashita, Richard D. Kolodner et al. · Proceedings of the National Academy of Sciences · 2003 · 174 citations

Life Sciences, Cell Biology, Molecular Biology +12

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer

Naohiro Tomita, Hideyuki Ishida, Kohji Tanakaya et al. · International Journal of Clinical Oncology · 2021 · 157 citations · Full text

Medicine, Oncology, Cancer Genetics +16